- Published at
- by manilatimes.net
positive
positive
News for Kadmon Holdings, Inc. (KDMN)
- Published at
- by gurufocus.com
positivepositiveAtea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors
BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. ( AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the disc- Published at
- by globenewswire.com
mixedmixed- Published at
- by seekingalpha.com
mixedmixedLyra: Negative EV With A Very Compelling Treatment For Chronic Rhinosinusitis In Phase 3
Lyra Therapeutics has lost almost 90% of its value since its IPO in 2020. Click here to see why LYRA stock is a Buy.- Published at
- by globenewswire.com
positivepositiveWilson Disease Drugs Market Worth USD 861.6 Mn by 2029 Technological development, R&D investments, Competitive Rivalry, and forecast 2029
Wilson Disease Drugs Market size was valued at USD 610.5 Mn. in 2021 and the total Wilson Disease Drugs revenue is expected to grow by 4.4 % from 2022 to...- Published at
- by prnewswire.com
mixedmixedGlobal Pulmonary Drugs Market to Surpass US$ 77.31 Billion by 2030 - Coherent Market Insights
/PRNewswire/ -- According to Coherent Market Insights, the global pulmonary drugs market is estimated to be valued at US$ 41.32 billion in 2022 and is expected...- Published at
- by globenewswire.com
neutralneutralGlobal Wilson’s Disease Treatment Market to Surpass US$ 854.5 Million by 2030, Says Coherent Market Insights (CMI)
Seattle, June 27, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global Wilson’s disease treatment market is estimated to be valued...- Published at
- by prnewswire.com
mixedmixedAt 9.2% CAGR, Scleroderma Diagnostics and Therapeutics Market Size To Hit US$ 4124.6 Million, Globally, By 2028 | Industry Trends, Share, Growth Rate, Value, Analysis & Forecast Report By ZMR
/PRNewswire/ -- As per Zion Market Research study, The global scleroderma diagnostics and therapeutics market was approximately USD 2232.5 million in 2021 and...- Published at
- by sec.gov
neutralneutralFrank B. Glassner (Release No. LR-25398; May 24, 2022)
The Securities and Exchange Commission today charged Frank B. Glassner, a California-based executive compensation consultant, with insider trading in advance of...- Published at
- by prnewswire.com
neutralneutralEvommune Announces Appointment of Kyle Carver as Chief Financial Officer
/PRNewswire/ -- Evommune, Inc., a clinical stage, biotechnology company dedicated to the development of transformative medicines for inflammatory diseases,...- Published at
- by globenewswire.com
mixedmixedGlobal Systemic Scleroderma Treatment Market to Surpass US$ 2,027.4 Million by 2028, Says Coherent Market Insights (CMI)
SEATTLE, March 10, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global systemic scleroderma treatment market is estimated to be...- Published at
- by prnewswire.com
mixedmixedLyra Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
/PRNewswire/ -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,...- Published at
- by gurufocus.com
mixedmixedCnh Partners Llc Buys Investors Bancorp Inc, Sanderson Farms Inc, Kadmon Holdings Inc, Sells , Willis Towers Watson PLC, W R Grace
GuruFocus Article or News written by insider and the topic is about:- Published at
- by gurufocus.com
mixedmixed- Published at
- by gurufocus.com
mixedmixedCrewe Advisors LLC Buys Ensign Group Inc, Pennant Group Inc, iShares Core S&P Mid-Cap ETF, Sells Pluralsight Inc, Kennametal Inc, VanEck Vectors Junior Gold Miners ETF
Crewe Advisors LLC Buys Ensign Group Inc, Pennant Group Inc, iShares Core S&P Mid-Cap ETF, Sells Pluralsight Inc, Kennametal Inc, VanEck Vectors Junior Gold Miners ETF, Stocks: ENSG,PNTG,IJH,JPST,PGX,MSFT,TPVG,USAK,GSBD,KDMN,RD, release date:Apr 21, 2021- Published at
- by newtraderu.com
mixedmixed